Log in to save to my catalogue

Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion...

Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10195643

Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study

About this item

Full title

Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study

Publisher

United States: Cureus Inc

Journal title

Curēus (Palo Alto, CA), 2023-05, Vol.15 (5), p.e39119-e39119

Language

English

Formats

Publication information

Publisher

United States: Cureus Inc

More information

Scope and Contents

Contents

The management of early rectal cancer is different from that of colon cancer in terms of radiotherapy (RT) requirements or neoadjuvant treatment. It is not clear how the course of rectal cancer differs from that of the colon in a metastatic setting or how it should be approached differently. This study aimed to evaluate outcomes after combining dow...

Alternative Titles

Full title

Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10195643

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10195643

Other Identifiers

ISSN

2168-8184

E-ISSN

2168-8184

DOI

10.7759/cureus.39119

How to access this item